ביומאקס בע"מ

BiomX is developing both natural and engineered phage cocktails and personalized treatments designed to target and destroy harmful bacteria in chronic diseases, including cystic fibrosis and diabetic foot osteomyelitis.

BiomX is developing synbio phage therapies to eradicate harmful bacteria in chronic diseases.

Therapeutics Companies, Physicians, Dermatologists, Pulmonologists.

Jonathan Solomon - CEO

Marina Wolfson - CFO